Sun, August 15, 2021
Fri, August 13, 2021
Thu, August 12, 2021

Geulah Livshits Maintained (VINC) at Strong Buy with Decreased Target to $30 on, Aug 13th, 2021

Geulah Livshits of Chardan Capital, Maintained "Vincerx Pharma, Inc." (VINC) at Strong Buy with Decreased Target from $33 to $30 on, Aug 13th, 2021.

Geulah, nor any peers, have made any analyst calls on VINC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30